What are the opening hours?

Monday 9am - 6pm Tuesday 9am - 6pm Wednesday 9am - 6pm Thursday 9am - 6pm Friday 9am - 6pm Saturday 9am - 6pm Sunday 9am - 6pm

http://www.genesisreferencelabs.com/

Genesis Reference Laboratories, 7924 Forest City Road #210, Orlando, FL (2026)

01/16/2026

The intentional or unintentional use of more than one substance within a short period of time is referred to as polysubstance use. Those who practice polysubstance use intentionally may do so to:

● Modify or enhance the effects of a single substance.
● Compensate for weakened effects of one substance.
● Prevent alcohol and op**te withdrawal symptoms.
● Attempt to alleviate some of the stresses related to previous trauma, life circumstances, and/or health issues.
● Replace their preferred drug of choice when it’s unavailable.

Unfortunately, polysubstance use isn’t rare, as those who use one substance often use another. In previous years, 90% of people with an opioid use disorder used more than 2 other substances within the last year, and more than 25% of these individuals had at least two other substance use disorders.

Despite its prevalence, polysubstance use is never safe. Even when prescription drugs are used in combination or with other substances, the effects of drug mixing can be unpredictable, stronger than either drug alone, and/or deadly.

Mixing two respiratory depressants such as alcohol and opioids (e.g., hydrocodone, oxycodone, etc.) is particularly dangerous. In fact, black-box warnings on prescription opioid labels advise against mixing these substances with alcohol, as doing so can produce severe respiratory depression, sedation, and heightened risk of overdose.

Combining alcohol with substances such as opioids also increases the risk of overdose toxicity and multiple other adverse health outcomes such as: over-sedation, impaired motor control, bodily injury, violence, risky sexual behavior, respiratory arrest, anoxic brain injury and other organ damage, alcohol and other substance use disorders, and fatal overdose.

To access this original American Addiction Centers webpage and learn more about the dangers of polysubstance use, please visit https://americanaddictioncenters.org/alcohol/mixing-opioids

To learn more about how Genesis Reference Laboratories can provide toxicology testing to aid in medication monitoring and detection of substance use, including alcohol, please call: (844) 510-0194.⁠

01/14/2026

Respiratory illnesses are commonly viral or bacterial. Some common viral respiratory illnesses include flu, COVID-19, RSV, adenovirus, rhinovirus/enterovirus, parainfluenza, and parvovirus B19. Important bacterial respiratory illnesses include pneumococcal disease or infection with Mycoplasma pneumoniae.

Respiratory viruses may affect both the upper respiratory tract (the vocal cords and above) and the lower respiratory tract (below the vocal cords). Some viruses that affect the nose and throat can progress to cause serious lung infections, such as pneumonia.

Even healthy people can get very sick from respiratory illnesses. In fact, last year, the Centers for Disease Control and Prevention (CDC) estimated that at least 1 million people were hospitalized and more than 70,000 people died from respiratory viral illnesses. Some people have risk factors that can increase their chances of getting very sick (severe illness). Those at higher risk of severe illness include:

Age: Adults who are 65 years and older and children younger than 2 years old are usually at higher risk for getting very sick from respiratory illnesses.

Underlying conditions: Having medical conditions (for example, chronic lung disease, heart disease, diabetes, or chronic kidney disease), a weakened immune system, disability, and/or being pregnant are conditions that might increase your risk.

To access this original CDC topic on the respiratory illnesses, please see https://www.cdc.gov/respiratory-viruses/about/index.html

To learn more about Genesis Reference Labs’ molecular testing offerings which include using PCR technology to identify COVID-19, influenza, RSV, and other important respiratory pathogens, please call: (844) 510-0194.

01/12/2026

We’re proud to start the year by recognizing our team members celebrating work anniversaries in January! Your continued commitment, professionalism, and dedication help drive our mission forward and make a meaningful impact every day. Thank you for growing with us—we’re grateful to have you on the Genesis Reference Labs team!

👏 Join us in celebrating these important milestones! 👏

01/09/2026

A tranquilizer called xylazine, a non-opioid sedative, is continuing to be found in the US illegal drug supply and linked to overdose deaths. Xylazine—which is not approved for use in people and can slow down the brain and breathing, make the heart beat slower, and lower blood pressure in people, is especially dangerous when combined with opioids like fentanyl.

Due to its impact on the opioid crisis, fentanyl mixed (adulterated) with xylazine was declared an emerging threat by the White House's Office of National Drug Control Policy. On July 11, 2023, the White House released a National Response Plan to address the emerging threat of fentanyl mixed with xylazine.

If an overdose involving xylazine is suspected, the Centers for Disease Control and Prevention (CDC) recommends the use of Naloxone. Naloxone should be given in response to any suspected drug overdose to reverse any possible opioid effects. Naloxone will not reverse the effects of xylazine. However, because xylazine is often used with opioids like fentanyl, naloxone should still be given. It's important to call 911 for additional medical treatment, especially since the effects of xylazine may continue after naloxone is given.

To access this original CDC webpage and learn more about xylazine, xylazine use, and overdoses involving xylazine, please see https://www.cdc.gov/overdose-prevention/about/what-you-should-know-about-xylazine.html

To learn more about how Genesis Reference Laboratories can provide toxicology testing to aid in medication monitoring and detection of substance use, including xylazine, please call: (844) 510-0194.⁠

01/07/2026

The teen years are a time of growth, exploration, and risk-taking. Some risk-taking may foster identity development and independence (e.g., running for student council, asking someone out on a date). However, some risk behaviors—such as using cannabis—can have adverse effects on a teen's health and well-being.

In 2022, 30.7% of US high school 12th graders reported using cannabis in the past year, and 6.3% reported using cannabis daily in the past 30 days. Past-year va**ng of cannabis declined from 2020 to 2021 and remained steady in 2022 following large increases in 2018 and 2019. However, many middle and high school students still reported past-year cannabis va**ng in 2022—6% of eighth graders, 15% of 10th graders, and 21% of 12th graders.

Compared with teens who do not use cannabis, teens who use cannabis are more likely to quit high school or not get a college degree.

The teen brain is actively developing and continues to develop until around age 25. Cannabis use during adolescence and young adulthood may harm the developing brain.

To access this original CDC content and learn more about the impact of cannabis and teens, please see: https://www.cdc.gov/cannabis/health-effects/cannabis-and-teens.html

To learn more about how Genesis Reference Laboratories can provide urine and oral fluid testing to aid in medication monitoring and detection of substance use, including the detection of THC and CBD, please call: (844) 510-0194.⁠

01/05/2026

We’re kicking off the new year by celebrating our team members with January birthdays! Your hard work, dedication, and positive spirit help set the tone for a successful year ahead. Wishing you all a happy birthday and an amazing year filled with health, growth, and success!

🎈 Help us celebrate our January birthday stars! 🎈

01/02/2026

Did You Know?

In 2024, the Drug Enforcement Administration (DEA) seized more than 60 million fentanyl-laced fake pills and nearly 8,000 pounds of fentanyl powder. The 2024 seizures are equivalent to more than 380 million lethal doses of fentanyl.

In 2025 fentanyl seizures already represent over 262 million deadly doses.
The DEA created the One Pill Can Kill campaign to help raise public awareness of a significant nationwide surge in counterfeit pills that are mass-produced in labs, deceptively marketed as legitimate, and are killing Americans at an unprecedented rate.

Visit https://www.dea.gov/onepill for resources for everyone, including teens, parents, educators and seniors, to better understand the threat of fake pills and fentanyl.

12/31/2025

Newborn syphilis is a deadly but preventable consequence of the nation's ongoing sexually transmitted infections (STI) epidemic.

New provisional CDC data show U.S. cases of newborn syphilis increased for the 12th consecutive year in 2024, with nearly 4,000 cases reported. In 2024, cases of newborn syphilis were:

● Up nearly 2% over 2023, notably lower than double-digit increases that occurred in some recent years.
● Up nearly 700% since 2015, when just 495 cases were reported.

The overall STI burden in the United States remains substantial, with more than 2.2 million cases reported in 2024, a 13% increase since 2015, according to these provisional data.

To access this original CDC webpage please see https://www.cdc.gov/media/releases/2025/2025-cdc-reports-latest-national-data-on-syphilis-in-newborns-and-sexually-transmitted-infections-stis.html

To learn more about Genesis Reference Labs’ molecular testing offerings which include using PCR technology to identify sexually transmitted infections, including the pathogen that causes syphilis, Treponema pallidum, please call: (844) 510-0194.

12/29/2025

Foodborne illnesses are commonly referred to as food poisoning. These illnesses are acquired from food and some foods are more likely than others to contain germs that cause food poisoning, including raw meats, dairy, and eggs.

Certain groups of people are at higher risk for severe illness from food poisoning. Higher risk groups include people who are aged 65 or older, children under the age of 5, people with weakened immune systems, and pregnant women.

The Centers for Disease Control and Prevention (CDC) estimates that each year, 48 million people get sick from a foodborne illness, 128,000 are hospitalized, and 3,000 die.

Depending on the type of pathogen, symptoms of food poisoning may vary. Symptoms can range from mild to serious and can last for a few hours or several days. The most common symptoms of food poisoning are: diarrhea, stomach pain or cramps, nausea, vomiting, and fever.

The CDC recommends visiting a healthcare provider if any symptoms become more severe, including bloody diarrhea, diarrhea that lasts more than 3 days, a high fever (temperature over 102°F), vomiting so often that you cannot keep liquids down and if there are signs of dehydration, which include not urinating (peeing) much, a dry mouth and throat, and/or feeling dizzy when standing up.

To access this original CDC topic on food safety and food poisoning, please see https://www.cdc.gov/food-safety/index.html

To learn more about Genesis Reference Labs’ molecular testing offerings which include using PCR technology to identify many gastrointestinal pathogens including several common causes of food poisoning, please call: (844) 510-0194.

12/26/2025

Excessive alcohol use—which refers to drinking in ways that can negatively impact health—is a leading preventable cause of death in this country.

Based on recent studies:

Alcohol is the most common substance used among people 12 and older in the United States.

Excessive alcohol use causes about 178,000 deaths each year and shortened the lives of those who died by an average of 24 years.

About two-thirds of alcohol-related deaths (117,000 deaths) are from chronic conditions, which develop from drinking alcohol over time. This includes several types of cancer, heart disease, liver disease, and alcohol use disorder.

Another one-third of alcohol-related deaths (about 61,000 deaths) occur from binge drinking or drinking too much on one occasion. Examples include motor vehicle crashes, alcohol-involved drug overdoses, alcohol poisonings, and deaths by su***de.

To access this original Centers for Disease Control and Prevention (CDC) webpage and learn more about excessive alcohol use, please see https://www.cdc.gov/alcohol/facts-stats/index.html

To learn more about how Genesis Reference Laboratories can provide toxicology testing to aid in medication monitoring and detection of substance use, including alcohol, please call: (844) 510-0194.⁠

12/24/2025

Infectious mononucleosis is a contagious disease most commonly caused by Epstein-Barr virus (EBV). Other viruses can also cause this disease.

Typically, these viruses spread most commonly through bodily fluids, especially saliva. However, these viruses can also spread through blood and semen during sexual contact, blood transfusions, and organ transplantations.

Infectious mononucleosis is common among teenagers and young adults, especially college students. At least 1 out of 4 teenagers and young adults who get infected with EBV will develop infectious mononucleosis.

Typical symptoms of infectious mononucleosis usually appear 4 to 6 weeks after infection with EBV. Symptoms may develop slowly and may not all occur at the same time.

Symptoms of infectious mononucleosis can include extreme fatigue, fever, sore throat, headaches and body aches, swollen lymph nodes in the neck and armpits, swollen liver or spleen or both, and rashes. While most people get better in 2 to 4 weeks, some may feel fatigued for several more weeks. Occasionally, the symptoms of infectious mononucleosis can last for 6 months or longer.

There is no vaccine to protect against infectious mononucleosis. To protect and limit the likelihood of infection, the CDC recommends avoiding kissing people who have infectious mononucleosis and avoiding sharing drinks, food, or personal items (like toothbrushes) with infected individuals.

To access this original CDC topic on infectious mononucleosis, please see https://www.cdc.gov/epstein-barr/about/mononucleosis.html

To learn more about Genesis Reference Labs’ molecular testing offerings which include using PCR technology to identify Epstein-Barr virus (EBV) and other important respiratory pathogens, please call: (844) 510-0194.

12/22/2025

This month, we’re proud to recognize the incredible team members celebrating work anniversaries in December. Your commitment, expertise, and dedication play a vital role in our success and the care we provide every day. Thank you for being such an important part of the Genesis Reference Labs family—we truly appreciate all that you do!

👏 Join us in celebrating these milestones! 👏

Genesis Reference Laboratories

01/16/2026

01/14/2026

01/12/2026

01/09/2026

01/07/2026

01/05/2026

01/02/2026

12/31/2025

12/29/2025

12/26/2025

12/24/2025

12/22/2025

Address

Opening Hours

Website

Alerts

Contact The Practice

Shortcuts

Share

Category

Monday	9am - 6pm
Tuesday	9am - 6pm
Wednesday	9am - 6pm
Thursday	9am - 6pm
Friday	9am - 6pm
Saturday	9am - 6pm
Sunday	9am - 6pm